?Save $ and ⬇️bad #COVID19 outcomes by using ultra low dose #Rituximab in #RheumatoidArthritis retreatmet after responding to 1g. Not quite same benefit and sl earlier repeat dosing. @RheumNow #ACR21 #ACRBest abst#1443 Impt study https://t.co/SFZKpTYJXP